文献速递外周动脉疾病

临床衰弱与慢性威胁性肢体缺血的肢体威胁严重程度及结局的关联

Associations of Clinical Frailty with Severity of Limb Threat and Outcomes in Chronic Limb-threatening Ischaemia.
PubMed 文献 · Ann Vasc Surg · 2021-05-02

本研究为回顾性队列研究,纳入2018年2月至2019年4月期间就诊于血管保肢门诊的198例年龄≥50岁的慢性威胁性肢体缺血(CLTI)患者,采用临床衰弱量表(CFS)评估衰弱,WIfI评分评估肢体威胁严重程度。结果显示衰弱与WIfI分期升高相关(P=0.025),衰弱患者更常接受非手术治疗(P=0.017)。单变量分析中衰弱(HR 1.91;95%CI 1.09, 3.34;P=0.024)和WIfI 4期(HR 3.29;95%CI 1.23, 8.80;P=0.018)与一年死亡或截肢相关,但多变量分析中仅WIfI 4期(HR 2.80;95%CI 1.04, 7.57;P=0.042)和Charlson合并症指数(HR 1.21;95%CI 1.03, 1.41;P=0.015)为独立关联因素,衰弱不再显著(HR 1.25;95%CI 0.67, 2.33;P=0.474)。

要点

  • CFS评估的衰弱在CLTI患者中患病率高(52%),且与WIfI分期升高相关。
  • 衰弱与一年死亡或截肢在单变量分析中相关,但多变量分析中独立关联的是WIfI 4期和CCI。
  • CFS可作为CLTI患者风险评估的辅助工具。

核心结论

  • 衰弱在CLTI患者中高度流行并与肢体威胁严重程度相关,CFS可作为风险评估的辅助工具。

研究设计与样本

  • 回顾性队列研究,利用前瞻性维护的血管保肢门诊数据库,纳入198例年龄≥50岁的CLTI患者,其中190例有CFS评分。

主要发现

  • 98例(52%)患者衰弱(CFS≥5),衰弱与WIfI分期升高相关(P=0.025)。
  • 衰弱患者更常接受非手术治疗(P=0.017)。
  • 单变量分析中衰弱(HR 1.91;95%CI 1.09, 3.34;P=0.024)和WIfI 4期(HR 3.29;95%CI 1.23, 8.80;P=0.018)与一年死亡或截肢相关。
  • 多变量分析中WIfI 4期(HR 2.80;95%CI 1.04, 7.57;P=0.042)和CCI(HR 1.21;95%CI 1.03, 1.41;P=0.015)独立关联结局,衰弱不显著(HR 1.25;95%CI 0.67, 2.33;P=0.474)。

临床怎么用

  • 使用CFS评估CLTI患者的衰弱状态,辅助识别高风险患者并指导治疗决策。

局限性

  • 回顾性研究设计,样本量有限,单中心数据,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Investigate the relationship of frailty and severity of chronic limb-threatening ischaemia (CLTI), and their comparative associations with one-year outcomes, in patients presenting to a vascular limb salvage (VaLS) clinic. METHODS: This retrospective cohort study utilised data collected from a prospectively maintained VaLS clinic database. Patients aged ≥50 presenting to the VaLS clinic with CLTI between February 2018 and April 2019 were included. Frailty was measured using the Clinical Frailty Scale (CFS) and limb threat severity by the Wound, Ischaemia, and foot Infection (WIfI) score. Excessive polypharmacy was defined as ≥10 medications. Anticholinergic burden (ACB) score and Charlson comorbidity index (CCI) were calculated for all patients. The primary outcome measure was a composite endpoint of death or amputation at one-year. Associations with outcome were assessed using Cox regression and reported as hazards ratios (HR) with 95% confidence intervals (CI). RESULTS: A total of 198 patients were included, with CFS scores available for 190 patients. 98 patients (52%) were frail (CFS ≥5). 127 patients (67%) initially underwent endovascular revascularisation. Excessive polypharmacy was common (55 patients; 28%). Frailty was associated with increased WIfI stage (P = 0.025) as well as age, female sex, CCI score, number of medications, excessive polypharmacy but not ACB score. Frail patients were more frequently managed non-operatively (P = 0.017). Frailty (HR 1.91; 95% CI 1.09, 3.34; P = 0.024) and WIfI stage 4 (HR 3.29; 95%CI 1.23, 8.80; P = 0.018) were associated with death or amputation on univariable analysis. WIfI stage 4 (HR 2.80; 95%CI 1.04, 7.57; P = 0.042) and CCI score (HR 1.21; 95%CI 1.03, 1.41; P = 0.015), but not frailty (HR 1.25; 95%CI 0.67, 2.33; P = 0.474), were independently associated with death or amputation on multivariable analysis. CONCLUSIONS: Frailty is highly prevalent among CLTI patients and related to severity of limb threat. The CFS may be a useful adjunct to patient risk assessment in CLTI.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Houghton JS, Nickinson AT, Helm JR, et al. Associations of Clinical Frailty with Severity of Limb Threat and Outcomes in Chronic Limb-threatening Ischaemia. Ann Vasc Surg. 2021. PMID: 33951523. doi:10.1016/j.avsg.2021.04.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。